Physician profile
Arif Ali
NPI 1679673164
$39,074.58
in general payments reported to CMS, 2019-2025
13 companies · $2,477 in 2025
The $2,477 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $14K · 2020: $11K · 2021: $2,149 · 2022: $2,412 · 2023: $723 · 2024: $6,591 · 2025: $2,477.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $6,300 · Food and Beverage: $2,237 · Travel and Lodging: $1,254.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $6,300.00 |
| Food and Beverage | $2,236.64 |
| Travel and Lodging | $1,254.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $25,661.41 | 2019-2025 | Blueprint Patient Specific Instrumentation, Gamma, Tornier Perform Reversed Augmented Glenoid |
| Medical Device Business Services, INC. | $8,570.21 | 2020-2024 | Na |
| Zimmer Biomet Holdings, INC. | $1,636.85 | 2019-2025 | Avenir, Comprehensive Shoulder System |
| Depuy Synthes Sales INC. | $1,325.21 | 2019-2025 | Tfn-Advance |
| Wright Medical Technology, INC. | $643.90 | 2019 | |
| Medwest Associates | $635.00 | 2019 | |
| Janssen Biotech, INC. | $171.39 | 2020-2021 | |
| Medacta USA, INC. | $161.85 | 2025 | Reverse Shoulder |
| Arthrex, INC. | $105.20 | 2021 | |
| Biosense Webster, INC. | $67.90 | 2024 | Carto 3 |
| Smith+Nephew, INC. | $36.37 | 2024 | Evos |
| Lightbody Medical Technologies INC | $32.10 | 2025 | |
| Orthofix Medical, INC. | $27.19 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Arif Ali listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.